Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
RINZ (RUSSIA)
Регистрационное агентство DOI (США)
DOI Registration Agency (USA)
Эко-Вектор (Россия)
Eco-Vector (Russia)
Ulrichsweb (Ulrich’s Periodicals Director

An interdisciplinary view on the problem of comorbid osteoporosis in old age

DOI: https://doi.org/10.29296/25879979-2022-07-01
Download full text PDF
Issue: 
7
Year: 
2022

V.I. Strukov( 1), D.G. Elistratov( 2), M.N. Maksimova( 1), L.G. Radchenko( 1), A.N. Astafieva (1), D.V. Vikhrev(1), N.Y. Alekseeva(1)
1-Penza Institute of Advanced Training of Doctors – branch of «RMAPO» of the Ministry of Health of the Russian Federation
2-Longevity Secrets Medical Center, Penza

Data on the clinical status of modern elderly patients with comorbid osteoporosis (OC) and geriatric syndrome are presented. The possibility of replacing antiresorbents with anabolic support with Osteomed Forte in elderly patients on the basis of an open prospective randomized trial is assessed.
Keywords: 
personalized approach
comorbid osteoporosis
cavities
bone mineral density
osteomed forte
polypragmasia
densitometry
geriatric syndrome

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Burmistrova L.A. Can we cure or suspend the development of postmenopausal osteoporosis? Lechashchyj doctor. 2014; 3: 91.
  2. Strukov V.I. et al. Actual problems of osteoporosis: monograph. Penza: ROSTRA, 2009.
  3. Strukov V.I. World’s discovery in the fight against fractures and osteoporosis! Polyclinic. 2012; 5: 126–127.
  4. Jones O., Strukov V. et al. Comorbid osteoporosis: problems and new possibilities of therapy (part 1, 2). Phys. 2017; 10: 23–26; 11: 25–28.
  5. Boykov I.V., Strukov V.I., Semerich Yu.С . Program for determining the degree of patient’s osteoporosis lesion. Certificate of state registration of computer program № 2013660284 dated 10.09.2013.
  6. Bokov. A.E. Prognostic significance of bone density determined by computed tomography in relation to low-energy fractures of the spine. Medical visualization. 2015; 3: 94–98.
  7. Isayeva S.M. Some issues of epidemiology and diagnosis of osteoporosis. Medicine (Almaty). 2018; 3 (188): 154–158.
  8. Kotelnikov G.P., Bulgakova S.V. Osteoporosis. Moscow: GEOTAR-Medicine, 2010.
  9. Traumatology: national guidelines / G.P. Kotelnikov, S.P. Mironova. GEOTAR-Medicine, 2008.
  10. Strukov V.I., Katyushina Y.G., Phillipova O.V. Osteomed – an effective regulator of bone mineral density and closure of cavities in the treatment of presynyl and senile osteoporosis. Polyclinic. 2013; 1(1): 90–91.
  11. Strukov V.I., Potapov V., Kislov A.I., Elistratov D.G. et al. Osteoporosis – a problem of the elderly: to accept or to treat? Phys. 2014; 6: 30–32.
  12. Strukov V.I., Burmistrova L., Elistratov D.G. et al. Osteoporosis: diagnosis and effective treatment. Vrach. 2014; 4: 52–54.
  13. Vertkin A.L., Naumov A.V. Osteoporosis. Guide for practical doctors. Moscow: Eksmo, 2015.
  14. Gromova O.A., Torshin I.Yu., Limanova O.A. Calcium and its synergists in support of connective and bone tissue structure. Lechashchyj doctor. 2014; 5: 2–7.
  15. Zakharov I.S. Evaluation of consistency of results of different methods of osteodensitometry in diagnosing osteoporosis in women. Polytrauma. 2015; 2: 59–63.
  16. Kalinichenko S.Y., Apetov S.S. The role of androgens in women: what do we know? Lechaychajnyj doctor. 2010; 8: 78–83.
  17. Оsteoporosis: clinical guidelines / Russian Association of Endocrinologists, Russian Association of Osteoporosis, Russian Association of Rheumatologists et al.; approved by. Scientific and Practical Council of the Ministry of Health of the Russian Federation, 2021.
  18. Pavlova T.V., Bashuk I.P. Clinical and morphological features of degenerative changes in bone tissue against osteoporosis in the age aspect. Phys. 2019; 6: 47–50.
  19. Patent 2511430 Russian Federation, MPK A 61 B 6/00, G 01 N 9/36, G 01 N 23/083. Method of osteoporosis diagnostics by determination of cavity closure dynamics for evaluation of effectiveness of different osteoprotectors application / Strukov V.I., Jones O., Krutyakov E.N., Elistratov K.G.; applicant and patent holder Parafarm Ltd. No. 2012115655/14; application. 19.04.2012; publ. 10.04.2014.
  20. Peshekhonova L.K., Peshekhonov D.V., Krasyukov P.A. Clinical efficacy of Osteomed, Osteomed Forte, Osteo-Vit D3 in patients with secondary osteoporosis in rheumatoid arthritis. Phys. 2020; 31 (4): 68–74.
  21. Raskachkin V.A., Tokarev A.V., Panov I.V. Biologically active drug “Osteomed” in the complex treatment of arthrosis of large joints. Phys. 2018; 1: 63–66.
  22. Rozhinskaya L.Ya. Diagnostics and treatment of osteoporosis. Clinical Gerontology. 2007; 2: 37–46.
  23. Samylina I.A., Strukov V.I., Petrova E.V. et al. Osteoprotective properties of combination HDBA organic complex with vitamins D3 and B6 (“Osteo-Vit D3”). Pharmacy. 2020; 69 (1): 48–56.
  24. 24. Strukov V.I., Sergeeva-Kondrachenko M.Yu., Marchenkova L.A., et al Immunotherapy of postmenopausal osteoporosis and other diseases of the osteoarticular system against the background of hormonal insufficiency Obstetrics and gynecology: news, opinions, training. 2022. 2 (10): 14-22
  25. 25. Strukov V., Elistratov D., Kislov A., et al. Osteoporosis in geriatric practice Vrach. 2018. 6(29): 26–30.
  26. Sergeeva-Kondrachenko M., Strukov V., Poluboyarinov P., et al. Type 2 diabetes mellitus and postmenopausal osteoporosis: how to improve the quality of life? Vrach. 2019. 11(30): 72–75
  27. Sergeeva-Kondrachenko M.Y. Treatment of women with menopausal syndrome: an alternative to menopausal hormone therapy. Vrach. 2022; 33 (7): 35–40.